Zhou Y - Search Results

1

Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.

Hirata TDC, Dagli-Hernandez C, Genvigir FDV, Lauschke VM, Zhou Y, Hirata MH, Hirata RDC. Hirata TDC, et al. Among authors: zhou y. Mol Diagn Ther. 2021 Nov;25(6):735-755. doi: 10.1007/s40291-021-00549-z. Epub 2021 Aug 6. Mol Diagn Ther. 2021. PMID: 34357562 Review.

2

Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.

Zhou Y, Ingelman-Sundberg M, Lauschke VM. Zhou Y, et al. Clin Pharmacol Ther. 2017 Oct;102(4):688-700. doi: 10.1002/cpt.690. Epub 2017 May 26. Clin Pharmacol Ther. 2017. PMID: 28378927 Free PMC article.

3

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions.

Vorrink SU, Zhou Y, Ingelman-Sundberg M, Lauschke VM. Vorrink SU, et al. Among authors: zhou y. Toxicol Sci. 2018 Jun 1;163(2):655-665. doi: 10.1093/toxsci/kfy058. Toxicol Sci. 2018. PMID: 29590495 Free PMC article.

4

Integrating rare genetic variants into pharmacogenetic drug response predictions.

Ingelman-Sundberg M, Mkrtchian S, Zhou Y, Lauschke VM. Ingelman-Sundberg M, et al. Among authors: zhou y. Hum Genomics. 2018 May 25;12(1):26. doi: 10.1186/s40246-018-0157-3. Hum Genomics. 2018. PMID: 29793534 Free PMC article.

5

Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.

Zhou Y, Lauschke VM. Zhou Y, et al. J Med Genet. 2018 Sep;55(9):617-627. doi: 10.1136/jmedgenet-2018-105429. Epub 2018 Jul 3. J Med Genet. 2018. PMID: 29970487

6

Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.

Zhou Y, Mägi R, Milani L, Lauschke VM. Zhou Y, et al. J Lipid Res. 2018 Oct;59(10):1987-2000. doi: 10.1194/jlr.P086710. Epub 2018 Aug 3. J Lipid Res. 2018. PMID: 30076208 Free PMC article.

7

An optimized prediction framework to assess the functional impact of pharmacogenetic variants.

Zhou Y, Mkrtchian S, Kumondai M, Hiratsuka M, Lauschke VM. Zhou Y, et al. Pharmacogenomics J. 2019 Apr;19(2):115-126. doi: 10.1038/s41397-018-0044-2. Epub 2018 Sep 12. Pharmacogenomics J. 2019. PMID: 30206299 Free PMC article.

8

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data.

Zhou Y, Fujikura K, Mkrtchian S, Lauschke VM. Zhou Y, et al. Front Pharmacol. 2018 Dec 4;9:1437. doi: 10.3389/fphar.2018.01437. eCollection 2018. Front Pharmacol. 2018. PMID: 30564131 Free PMC article. Review.

9

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity.

Lauschke VM, Zhou Y, Ingelman-Sundberg M. Lauschke VM, et al. Among authors: zhou y. Pharmacol Ther. 2019 May;197:122-152. doi: 10.1016/j.pharmthera.2019.01.002. Epub 2019 Jan 22. Pharmacol Ther. 2019. PMID: 30677473 Free PMC article. Review.

10

CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma.

Lauschke VM, Nordling Å, Zhou Y, Fontalva S, Barragan I, Ingelman-Sundberg M. Lauschke VM, et al. Among authors: zhou y. Pharmacogenomics. 2019 Oct;20(15):1085-1092. doi: 10.2217/pgs-2019-0094. Pharmacogenomics. 2019. PMID: 31588878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,477 results

Search Page

Filters